Thuja Occidentalis - Aidance Skincare & Topical Solutions, LLC

Manufacturer: Aidance Skincare & Topical Solutions, LLC
Effective date: 2012-09-19
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-06-01 02:04:04

Label at a glance#

ProductTerrasil Wart Treatment Maximum Strength

Active ingredientTHUJA OCCIDENTALIS LEAFY TWIG

Label structure7 sections

Indications and uses

For the treatment of warts

Dosage and administration

Wash and dry affected skin. Apply a thin layer of Terrasil. Repeat procedure 2-3 times daily until skin improves. Warts will dry and flake away over 3 to 6 week period. Store at room temperature.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Thuja Occidentalis

The letters HPUS indicate the component(s) in this product is (are) officially monographed in the Homeopathic Pharmacopeia of the United States

Purpose

OTC - PURPOSE SECTION

Wart Symptom Relief

Uses

INDICATIONS & USAGE SECTION

For the treatment of warts

Warnings

WARNINGS SECTION

For external use only.
Ask a doctor before use if pregnant or nursing.
When using this product, do not get into eyes.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, call poison control or seek medical help.

Directions

DOSAGE & ADMINISTRATION SECTION

Wash and dry affected skin. Apply a thin layer of Terrasil. Repeat procedure 2-3 times daily until skin improves. Warts will dry and flake away over 3 to 6 week period. Store at room temperature.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

cera alba (organic beeswax), juniperus virginiana oil (cedarwood oil), silver oxide, magnesium oxide, simmondsia chinensis (jojoba) seed oil, zinc oxide

PRINCIPAL DISPLAY PANEL - 44g Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

terrasil MAX

Maximum Strength
Wart Treatment
Fast - Painless - All-Natural

Jar Label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
24909-114-14	2020-01-31	C162847	48780-1	9d75b9cf-e34b-f424-e053-dadaa90a57ce	Drug Facts
24909-114-44	2020-01-31	C162847	48780-1	9d75b9cf-e34b-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
24909-114-14	Terrasil Wart TreatmentMaximum Strength	14 g in 1 JAR	OINTMENT	14		2
24909-114-44	Terrasil Wart TreatmentMaximum Strength	44 g in 1 JAR	OINTMENT	44		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
24909-114	TERRASIL WART TREATMENT MAXIMUM STRENGTH (THUJA OCCIDENTALIS) OINTMENT [AIDANCE SKINCARE & TOPICAL SOLUTIONS, LLC]	2	Legacy NDC, 2 package rows	20121018_5cb37519-e83d-4507-8e4e-3271f883a2d4.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
THUJA OCCIDENTALIS LEAFY TWIG	ACTIVE INGREDIENT	1NT28V9397	2
THUJA OCCIDENTALIS LEAFY TWIG	ACTIVE MOIETY	1NT28V9397	2
JOJOBA OIL	INACTIVE INGREDIENT	724GKU717M	2
JUNIPERUS VIRGINIANA OIL	INACTIVE INGREDIENT	PAD4FN7P2G	2
MAGNESIUM OXIDE	INACTIVE INGREDIENT	3A3U0GI71G	2
SILVER OXIDE	INACTIVE INGREDIENT	897WUN6G6T	2
WHITE WAX	INACTIVE INGREDIENT	7G1J5DA97F	2
ZINC OXIDE	INACTIVE INGREDIENT	SOI2LOH54Z	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

Terrasil Wart Treatment Maximum Strength
Thuja Occidentalis
THUJA OCCIDENTALIS LEAFY TWIG
JOJOBA OIL
JUNIPERUS VIRGINIANA OIL
MAGNESIUM OXIDE
SILVER OXIDE
WHITE WAX
ZINC OXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
24909-114	24909-114-14, 24909-114-44

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
THUJA OCCIDENTALIS LEAFY TWIG	1NT28V9397	ACTIB
JOJOBA OIL	724GKU717M	IACT
JUNIPERUS VIRGINIANA OIL	PAD4FN7P2G	IACT
MAGNESIUM OXIDE	3A3U0GI71G	IACT
SILVER OXIDE	897WUN6G6T	IACT
WHITE WAX	7G1J5DA97F	IACT
ZINC OXIDE	SOI2LOH54Z	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 30 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
MAGNESIUM OXIDE	MAGNESIUM OXIDE	3A3U0GI71G	CAPSULE / ORAL		20 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
ZINC OXIDE	ZINC OXIDE	SOI2LOH54Z	LOTION / TOPICAL	16 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	LOTION / TOPICAL	1 %w/w		Exact identifier — unii candidate 15 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	CAPSULE, EXTENDED RELEASE / ORAL		71 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	CREAM / TOPICAL		500 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	TABLET, FILM COATED / ORAL	0.2 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	CREAM / VAGINAL		40 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	CREAM, AUGMENTED / TOPICAL	10 %w/w		Exact identifier — unii candidate 15 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	TABLET, EXTENDED RELEASE / ORAL	14 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
MAGNESIUM OXIDE	MAGNESIUM OXIDE	3A3U0GI71G	TABLET, FILM COATED / ORAL		80 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	OINTMENT, AUGMENTED / TOPICAL		429 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
MAGNESIUM OXIDE	MAGNESIUM OXIDE	3A3U0GI71G	TABLET / ORAL		63 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
ZINC OXIDE	ZINC OXIDE	SOI2LOH54Z	SUPPOSITORY / RECTAL	375 mg		Exact identifier — unii candidate 6 equally ranked IID candidates
MAGNESIUM OXIDE	MAGNESIUM OXIDE	3A3U0GI71G	CAPSULE, EXTENDED RELEASE / ORAL		75 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	CAPSULE / ORAL		79 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
MAGNESIUM OXIDE	MAGNESIUM OXIDE	3A3U0GI71G	TABLET, DELAYED RELEASE / ORAL		368 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
MAGNESIUM OXIDE	MAGNESIUM OXIDE	3A3U0GI71G	GUM, CHEWING / BUCCAL		173 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
MAGNESIUM OXIDE	MAGNESIUM OXIDE	3A3U0GI71G	TABLET, EXTENDED RELEASE / ORAL	25.74 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	TABLET, COATED / ORAL	3 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
ZINC OXIDE	ZINC OXIDE	SOI2LOH54Z	INJECTION / SUBCUTANEOUS	0.02 %w/v		Exact identifier — unii candidate 6 equally ranked IID candidates
MAGNESIUM OXIDE	MAGNESIUM OXIDE	3A3U0GI71G	CAPSULE, DELAYED RELEASE / ORAL		78 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	OINTMENT / TOPICAL		2100 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
MAGNESIUM OXIDE	MAGNESIUM OXIDE	3A3U0GI71G	TABLET / SUBLINGUAL		15 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
ZINC OXIDE	ZINC OXIDE	SOI2LOH54Z	SOLUTION / INTRAVENOUS	3.11 %w/v		Exact identifier — unii candidate 6 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	SUPPOSITORY / RECTAL	265 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	AEROSOL, FOAM / TOPICAL	2 %w/w		Exact identifier — unii candidate 15 equally ranked IID candidates
ZINC OXIDE	ZINC OXIDE	SOI2LOH54Z	INJECTION, SUSPENSION / SUBCUTANEOUS	NA		Exact identifier — unii candidate 6 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	TABLET / ORAL	5 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
WHITE WAX	WHITE WAX	7G1J5DA97F	TABLET, DELAYED RELEASE / ORAL	0.08 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
ZINC OXIDE	ZINC OXIDE	SOI2LOH54Z	SOLUTION / RESPIRATORY (INHALATION)	3.11 %w/v		Exact identifier — unii candidate 6 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
5a388f0b-5e1c-4eea-8e2d-9ec8608a3d80			5cb37519-e83d-4507-8e4e-3271f883a2d4	2012-09-19	Warnings	Exact identifier spl id: 5a388f0b-5e1c-4eea-8e2d-9ec8608a3d80 spl set id: 5cb37519-e83d-4507-8e4e-3271f883a2d4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.